These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 22100780)
1. [Tripeptidyl peptidase 1 in patients with late infantile neuronal ceroid lipofuscinosis]. Contreras LM; Luengo WD; Zerpa N; Hernández JC; Chávez CJ; Ferrer SG An Pediatr (Barc); 2012 Mar; 76(3):148-52. PubMed ID: 22100780 [TBL] [Abstract][Full Text] [Related]
2. Clinico-investigative profile of infantile and late-infantile neuronal ceroid lipofuscinoses. Kamate M; Prashanth GP; Hattiholi V Neurol India; 2012; 60(3):316-20. PubMed ID: 22824694 [TBL] [Abstract][Full Text] [Related]
3. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs. Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052 [TBL] [Abstract][Full Text] [Related]
4. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes. Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752 [TBL] [Abstract][Full Text] [Related]
5. Exclusion of late infantile neuronal ceroid lipofuscinosis (LINCL) in a fetus by assay of tripeptidyl peptidase I in chorionic villi. Young EP; Winchester BG; Peter Logan W; Wheeler RB; Lake BD Prenat Diagn; 2000 Apr; 20(4):337-9. PubMed ID: 10740208 [TBL] [Abstract][Full Text] [Related]
6. Clinical study in Chinese patients with late-infantile form neuronal ceroid lipofuscinoses. Chang X; Huang Y; Meng H; Jiang Y; Wu Y; Xiong H; Wang S; Qin J Brain Dev; 2012 Oct; 34(9):739-45. PubMed ID: 22245569 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of late-infantile neuronal ceroid lipofuscinosis using dried blood spot-based assay for TPPI enzyme activity: TPPI diagnostic assay from DBS. Gavin M; Khatoon S; Marchi EJ; Mevs CA; Bolton DC; Velinov MT; Junaid MA Clin Chim Acta; 2020 Aug; 507():62-68. PubMed ID: 32298681 [TBL] [Abstract][Full Text] [Related]
8. Prenatal testing for late infantile neuronal ceroid lipofuscinosis. Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500 [TBL] [Abstract][Full Text] [Related]
10. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis. Bernardini F; Warburton MJ Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of late-infantile neuronal ceroid lipofuscinosis: a new sensitive method to assay lysosomal pepstatin-insensitive proteinase activity in human and animal specimens by capillary electrophoresis. Viglio S; Marchi E; Wisniewski K; Casado B; Cetta G; Iadarola P Electrophoresis; 2001 Jul; 22(11):2343-50. PubMed ID: 11504071 [TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease). Sun Y; Almomani R; Breedveld GJ; Santen GW; Aten E; Lefeber DJ; Hoff JI; Brusse E; Verheijen FW; Verdijk RM; Kriek M; Oostra B; Breuning MH; Losekoot M; den Dunnen JT; van de Warrenburg BP; Maat-Kievit AJ Hum Mutat; 2013 May; 34(5):706-13. PubMed ID: 23418007 [TBL] [Abstract][Full Text] [Related]
13. [Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation]. Bukina AM; Tsvetkova IV; Semiachkina AN; Il'ina ES Vopr Med Khim; 2002; 48(6):594-8. PubMed ID: 12698559 [TBL] [Abstract][Full Text] [Related]
14. The neuronal ceroid-lipofuscinoses. Bennett MJ; Rakheja D Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013 [TBL] [Abstract][Full Text] [Related]
15. R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis. Barisić N; Logan P; Pikija S; Skarpa D; Blau N Croat Med J; 2003 Aug; 44(4):489-93. PubMed ID: 12950156 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis. Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878 [TBL] [Abstract][Full Text] [Related]
17. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis. Yu F; Liu XM; Chen YH; Zhang SQ; Wang K Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578 [No Abstract] [Full Text] [Related]
18. Chorea in Late-Infantile Neuronal Ceroid Lipofuscinosis: An Atypical Presentation. Saini AG; Sankhyan N; Singhi P Pediatr Neurol; 2016 Jul; 60():75-8. PubMed ID: 27343025 [TBL] [Abstract][Full Text] [Related]
19. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316 [TBL] [Abstract][Full Text] [Related]